PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,049,699 | +568.9% | 131,998 | +773.6% | 0.03% | +650.0% |
| Q2 2023 | $605,418 | -80.4% | 15,109 | -80.0% | 0.00% | -78.9% |
| Q1 2023 | $3,085,805 | -56.7% | 75,614 | -59.1% | 0.02% | -54.8% |
| Q4 2022 | $7,130,225 | +411.9% | 184,673 | +605.1% | 0.04% | +425.0% |
| Q3 2022 | $1,393,000 | +139.8% | 26,192 | +162.9% | 0.01% | +100.0% |
| Q2 2022 | $581,000 | -30.0% | 9,963 | -8.4% | 0.00% | -42.9% |
| Q1 2022 | $830,000 | -78.0% | 10,871 | -82.7% | 0.01% | -80.6% |
| Q4 2021 | $3,771,000 | +17.9% | 62,669 | +9.7% | 0.04% | -10.0% |
| Q3 2021 | $3,199,000 | +14.6% | 57,133 | +24.2% | 0.04% | +29.0% |
| Q2 2021 | $2,792,000 | +71.2% | 46,016 | +97.7% | 0.03% | +47.6% |
| Q1 2021 | $1,631,000 | -26.8% | 23,270 | -37.5% | 0.02% | -32.3% |
| Q4 2020 | $2,228,000 | -37.6% | 37,228 | -37.3% | 0.03% | -41.5% |
| Q3 2020 | $3,571,000 | +28.7% | 59,400 | +12.4% | 0.05% | +10.4% |
| Q2 2020 | $2,774,000 | +136.7% | 52,866 | +51.3% | 0.05% | +50.0% |
| Q1 2020 | $1,172,000 | -56.1% | 34,940 | -40.7% | 0.03% | -34.7% |
| Q4 2019 | $2,668,000 | +80.6% | 58,886 | +51.8% | 0.05% | +69.0% |
| Q3 2019 | $1,477,000 | -39.7% | 38,800 | -31.1% | 0.03% | -35.6% |
| Q2 2019 | $2,448,000 | +36.1% | 56,278 | +19.1% | 0.04% | -22.4% |
| Q1 2019 | $1,799,000 | +149.9% | 47,256 | +182.5% | 0.06% | +70.6% |
| Q4 2018 | $720,000 | +389.8% | 16,729 | +458.0% | 0.03% | +325.0% |
| Q3 2018 | $147,000 | -31.3% | 2,998 | -55.0% | 0.01% | -27.3% |
| Q2 2018 | $214,000 | +2040.0% | 6,665 | +1925.8% | 0.01% | +1000.0% |
| Q1 2018 | $10,000 | -95.3% | 329 | -92.9% | 0.00% | -90.9% |
| Q4 2017 | $211,000 | +124.5% | 4,633 | +85.3% | 0.01% | +120.0% |
| Q3 2017 | $94,000 | -38.2% | 2,500 | -21.7% | 0.01% | -50.0% |
| Q2 2017 | $152,000 | +130.3% | 3,194 | +121.5% | 0.01% | +100.0% |
| Q1 2017 | $66,000 | -68.3% | 1,442 | -77.6% | 0.01% | -70.6% |
| Q4 2016 | $208,000 | +55.2% | 6,440 | +62.1% | 0.02% | +112.5% |
| Q2 2016 | $134,000 | -56.1% | 3,974 | -30.9% | 0.01% | -52.9% |
| Q1 2016 | $305,000 | -63.6% | 5,748 | -47.3% | 0.02% | -65.3% |
| Q4 2015 | $837,000 | -5.7% | 10,900 | -49.5% | 0.05% | +8.9% |
| Q3 2015 | $888,000 | +235.1% | 21,599 | +476.7% | 0.04% | +246.2% |
| Q2 2015 | $265,000 | -68.9% | 3,745 | -61.0% | 0.01% | -69.0% |
| Q1 2015 | $853,000 | +153.1% | 9,596 | +152.7% | 0.04% | +133.3% |
| Q4 2014 | $337,000 | +316.0% | 3,798 | +353.8% | 0.02% | +260.0% |
| Q3 2014 | $81,000 | -41.3% | 837 | -44.3% | 0.01% | -37.5% |
| Q2 2014 | $138,000 | – | 1,502 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |